CHEMED CORP (CHE) Fundamental Analysis & Valuation
NYSE:CHE • US16359R1032
Current stock price
368.59 USD
-3.36 (-0.9%)
At close:
368.59 USD
0 (0%)
After Hours:
This CHE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CHE Profitability Analysis
1.1 Basic Checks
- In the past year CHE was profitable.
- CHE had a positive operating cash flow in the past year.
- CHE had positive earnings in each of the past 5 years.
- In the past 5 years CHE always reported a positive cash flow from operatings.
1.2 Ratios
- CHE has a better Return On Assets (17.24%) than 100.00% of its industry peers.
- CHE has a better Return On Equity (27.08%) than 93.00% of its industry peers.
- CHE's Return On Invested Capital of 21.08% is amongst the best of the industry. CHE outperforms 94.00% of its industry peers.
- CHE had an Average Return On Invested Capital over the past 3 years of 21.04%. This is significantly above the industry average of 8.74%.
- The last Return On Invested Capital (21.08%) for CHE is above the 3 year average (21.04%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.24% | ||
| ROE | 27.08% | ||
| ROIC | 21.08% |
ROA(3y)17.23%
ROA(5y)17.8%
ROE(3y)26.22%
ROE(5y)30.6%
ROIC(3y)21.04%
ROIC(5y)22.31%
1.3 Margins
- The Profit Margin of CHE (10.48%) is better than 97.00% of its industry peers.
- CHE's Profit Margin has declined in the last couple of years.
- The Operating Margin of CHE (14.01%) is better than 86.00% of its industry peers.
- In the last couple of years the Operating Margin of CHE has declined.
- The Gross Margin of CHE (32.54%) is better than 64.00% of its industry peers.
- CHE's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.01% | ||
| PM (TTM) | 10.48% | ||
| GM | 32.54% |
OM growth 3Y-4.39%
OM growth 5Y-2.39%
PM growth 3Y-3.57%
PM growth 5Y-7.36%
GM growth 3Y-3.17%
GM growth 5Y-0.72%
2. CHE Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CHE is creating value.
- Compared to 1 year ago, CHE has less shares outstanding
- CHE has less shares outstanding than it did 5 years ago.
- CHE has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 10.56 indicates that CHE is not in any danger for bankruptcy at the moment.
- CHE has a better Altman-Z score (10.56) than 94.00% of its industry peers.
- CHE has a debt to FCF ratio of 0.03. This is a very positive value and a sign of high solvency as it would only need 0.03 years to pay back of all of its debts.
- The Debt to FCF ratio of CHE (0.03) is better than 92.00% of its industry peers.
- CHE has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
- Looking at the Debt to Equity ratio, with a value of 0.01, CHE belongs to the top of the industry, outperforming 84.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.03 | ||
| Altman-Z | 10.56 |
ROIC/WACC2.32
WACC9.09%
2.3 Liquidity
- A Current Ratio of 1.05 indicates that CHE should not have too much problems paying its short term obligations.
- CHE has a worse Current ratio (1.05) than 67.00% of its industry peers.
- A Quick Ratio of 1.03 indicates that CHE should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.03, CHE is doing worse than 63.00% of the companies in the same industry.
- CHE does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.03 |
3. CHE Growth Analysis
3.1 Past
- The earnings per share for CHE have decreased by -6.70% in the last year.
- CHE shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.61% yearly.
- Looking at the last year, CHE shows a small growth in Revenue. The Revenue has grown by 4.06% in the last year.
- Measured over the past years, CHE shows a small growth in Revenue. The Revenue has been growing by 4.00% on average per year.
EPS 1Y (TTM)-6.7%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%-6%
Revenue 1Y (TTM)4.06%
Revenue growth 3Y5.82%
Revenue growth 5Y4%
Sales Q2Q%-0.1%
3.2 Future
- The Earnings Per Share is expected to grow by 10.57% on average over the next years. This is quite good.
- The Revenue is expected to grow by 5.60% on average over the next years.
EPS Next Y12.32%
EPS Next 2Y12.04%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue Next Year4.74%
Revenue Next 2Y5.44%
Revenue Next 3Y5.6%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. CHE Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 17.07 indicates a rather expensive valuation of CHE.
- Based on the Price/Earnings ratio, CHE is valued a bit cheaper than the industry average as 70.00% of the companies are valued more expensively.
- When comparing the Price/Earnings ratio of CHE to the average of the S&P500 Index (24.89), we can say CHE is valued slightly cheaper.
- The Price/Forward Earnings ratio is 15.20, which indicates a correct valuation of CHE.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of CHE indicates a somewhat cheap valuation: CHE is cheaper than 73.00% of the companies listed in the same industry.
- CHE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.07 | ||
| Fwd PE | 15.2 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHE indicates a somewhat cheap valuation: CHE is cheaper than 64.00% of the companies listed in the same industry.
- 71.00% of the companies in the same industry are more expensive than CHE, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.59 | ||
| EV/EBITDA | 11.93 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- CHE has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.39
PEG (5Y)4.73
EPS Next 2Y12.04%
EPS Next 3Y10.57%
5. CHE Dividend Analysis
5.1 Amount
- With a yearly dividend of 0.65%, CHE is not a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 0.50, CHE pays a better dividend. On top of this CHE pays more dividend than 81.00% of the companies listed in the same industry.
- With a Dividend Yield of 0.65, CHE pays less dividend than the S&P500 average, which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.65% |
5.2 History
- On average, the dividend of CHE grows each year by 11.06%, which is quite nice.
- CHE has been paying a dividend for at least 10 years, so it has a reliable track record.
- CHE has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)11.06%
Div Incr Years16
Div Non Decr Years21
5.3 Sustainability
- CHE pays out 11.95% of its income as dividend. This is a sustainable payout ratio.
- CHE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP11.95%
EPS Next 2Y12.04%
EPS Next 3Y10.57%
CHE Fundamentals: All Metrics, Ratios and Statistics
368.59
-3.36 (-0.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25 2026-02-25/amc
Earnings (Next)04-21 2026-04-21
Inst Owners101.6%
Inst Owner Change42.44%
Ins Owners1.54%
Ins Owner Change-0.72%
Market Cap5.08B
Revenue(TTM)2.53B
Net Income(TTM)265.24M
Analysts75
Price Target451.86 (22.59%)
Short Float %3.43%
Short Ratio2.24
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.65% |
Yearly Dividend2.24
Dividend Growth(5Y)11.06%
DP11.95%
Div Incr Years16
Div Non Decr Years21
Ex-Date02-23 2026-02-23 (0.6)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.47%
Min EPS beat(2)-10.06%
Max EPS beat(2)-2.88%
EPS beat(4)1
Avg EPS beat(4)-6.89%
Min EPS beat(4)-15.11%
Max EPS beat(4)0.5%
EPS beat(8)1
Avg EPS beat(8)-5.02%
EPS beat(12)3
Avg EPS beat(12)-3.1%
EPS beat(16)7
Avg EPS beat(16)-1.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.56%
Min Revenue beat(2)-3.96%
Max Revenue beat(2)-1.17%
Revenue beat(4)0
Avg Revenue beat(4)-1.96%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)-0.19%
Revenue beat(8)0
Avg Revenue beat(8)-1.64%
Revenue beat(12)2
Avg Revenue beat(12)-1.3%
Revenue beat(16)2
Avg Revenue beat(16)-1.4%
PT rev (1m)-20.25%
PT rev (3m)-22.86%
EPS NQ rev (1m)-10.94%
EPS NQ rev (3m)-10.94%
EPS NY rev (1m)-5.51%
EPS NY rev (3m)-5.76%
Revenue NQ rev (1m)-2.28%
Revenue NQ rev (3m)-2.28%
Revenue NY rev (1m)-1.24%
Revenue NY rev (3m)-1.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.07 | ||
| Fwd PE | 15.2 | ||
| P/S | 2.01 | ||
| P/FCF | 15.59 | ||
| P/OCF | 13.07 | ||
| P/B | 5.18 | ||
| P/tB | 22.1 | ||
| EV/EBITDA | 11.93 |
EPS(TTM)21.59
EY5.86%
EPS(NY)24.25
Fwd EY6.58%
FCF(TTM)23.64
FCFY6.41%
OCF(TTM)28.2
OCFY7.65%
SpS183.73
BVpS71.13
TBVpS16.68
PEG (NY)1.39
PEG (5Y)4.73
Graham Number185.88
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.24% | ||
| ROE | 27.08% | ||
| ROCE | 28.33% | ||
| ROIC | 21.08% | ||
| ROICexc | 22.41% | ||
| ROICexgc | 60.78% | ||
| OM | 14.01% | ||
| PM (TTM) | 10.48% | ||
| GM | 32.54% | ||
| FCFM | 12.86% |
ROA(3y)17.23%
ROA(5y)17.8%
ROE(3y)26.22%
ROE(5y)30.6%
ROIC(3y)21.04%
ROIC(5y)22.31%
ROICexc(3y)24.14%
ROICexc(5y)24.65%
ROICexgc(3y)64.18%
ROICexgc(5y)68.12%
ROCE(3y)28.21%
ROCE(5y)29.9%
ROICexgc growth 3Y-2.67%
ROICexgc growth 5Y-7.4%
ROICexc growth 3Y-2.26%
ROICexc growth 5Y-2.45%
OM growth 3Y-4.39%
OM growth 5Y-2.39%
PM growth 3Y-3.57%
PM growth 5Y-7.36%
GM growth 3Y-3.17%
GM growth 5Y-0.72%
F-Score6
Asset Turnover1.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.03 | ||
| Debt/EBITDA | 0.03 | ||
| Cap/Depr | 96.84% | ||
| Cap/Sales | 2.48% | ||
| Interest Coverage | 263.51 | ||
| Cash Conversion | 92.61% | ||
| Profit Quality | 122.71% | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 10.56 |
F-Score6
WACC9.09%
ROIC/WACC2.32
Cap/Depr(3y)89.6%
Cap/Depr(5y)92.99%
Cap/Sales(3y)2.34%
Cap/Sales(5y)2.49%
Profit Quality(3y)114.97%
Profit Quality(5y)107.83%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.7%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%-6%
EPS Next Y12.32%
EPS Next 2Y12.04%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue 1Y (TTM)4.06%
Revenue growth 3Y5.82%
Revenue growth 5Y4%
Sales Q2Q%-0.1%
Revenue Next Year4.74%
Revenue Next 2Y5.44%
Revenue Next 3Y5.6%
Revenue Next 5YN/A
EBIT growth 1Y-12.87%
EBIT growth 3Y1.18%
EBIT growth 5Y1.52%
EBIT Next Year25.84%
EBIT Next 3Y13.68%
EBIT Next 5YN/A
FCF growth 1Y-11.55%
FCF growth 3Y8.82%
FCF growth 5Y-5.44%
OCF growth 1Y-7%
OCF growth 3Y7.8%
OCF growth 5Y-4.52%
CHEMED CORP / CHE Fundamental Analysis FAQ
What is the fundamental rating for CHE stock?
ChartMill assigns a fundamental rating of 7 / 10 to CHE.
What is the valuation status of CHEMED CORP (CHE) stock?
ChartMill assigns a valuation rating of 5 / 10 to CHEMED CORP (CHE). This can be considered as Fairly Valued.
Can you provide the profitability details for CHEMED CORP?
CHEMED CORP (CHE) has a profitability rating of 8 / 10.
Can you provide the financial health for CHE stock?
The financial health rating of CHEMED CORP (CHE) is 8 / 10.
What is the earnings growth outlook for CHEMED CORP?
The Earnings per Share (EPS) of CHEMED CORP (CHE) is expected to grow by 12.32% in the next year.